Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Yohimbine | IC50 | 27.1 [1] | |
| Yohimbine | Ki | 2.3 [1] | |
| Clonidine | Ki | 9.33 [1], 30.0 [2], 56.23 [3], 160.0 [4] | |
| Terazosin | Ki | 78.0 [1], 170.0 [2], 213.0 [3], 223.87 [4], 878.0 [5] | |
| (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 0.5 [1], 4.8 [2], 6.2 [3], 8.8 [4] | |
MLA | "Quest Database™ Alpha-2c adrenergic receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 16 Jun. 2026, https://www.aatbio.com/data-sets/alpha-2c-adrenergic-receptor-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, June 16). Quest Database™ Alpha-2c adrenergic receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/alpha-2c-adrenergic-receptor-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |